Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer

被引:10
作者
Vinh-Hung, Vincent [1 ]
Everaert, Hendrik [2 ]
Lamote, Jan [3 ]
Voordeckers, Mia [5 ]
van Parijs, Hilde [5 ]
Vanhoeij, Marian [3 ]
Verfaillie, Guy [3 ]
Fontaine, Christel [4 ]
Vees, Hansjoerg [1 ]
Ratib, Osman [1 ]
Vlastos, Georges [6 ]
De Ridder, Mark [5 ]
机构
[1] Univ Geneva, Univ Hosp Geneva, Dept Imaging & Med Informat Sci, CH-1211 Geneva 14, Switzerland
[2] Vrije Univ Brussel, UZ Brussel, Dept Nucl Med, Brussels, Belgium
[3] Vrije Univ Brussel, UZ Brussel, Dept Surg, Brussels, Belgium
[4] Vrije Univ Brussel, UZ Brussel, Dept Med Oncol, Brussels, Belgium
[5] Vrije Univ Brussel, UZ Brussel, Dept Radiotherapy, Brussels, Belgium
[6] Univ Geneva, Univ Hosp Geneva, Dept Surg Senol, CH-1211 Geneva 14, Switzerland
关键词
Breast cancer; Prognosis; Survival; Lymph nodes; Staging; Surgery; F-18-FDG PET; ASSOCIATION; WOMEN; CT;
D O I
10.1007/s00259-012-2181-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To explore the preoperative utility of FDG PET for the diagnosis and prognosis in a retrospective breast cancer case series. In this retrospective study, 104 patients who had undergone a preoperative FDG PET scan for primary breast cancer at the UZ Brussel during the period 2002-2008 were identified. Selection criteria were: histological confirmation, FDG PET performed prior to therapy, and breast surgery integrated into the primary therapy plan. Patterns of increased metabolism were recorded according to the involved locations: breast, ipsilateral axillary region, internal mammary chain, or distant organs. The end-point for the survival analysis using Cox proportional hazards was disease-free survival. The contribution of prognostic factors was evaluated using the Akaike information criterion and the Nagelkerke index. PET positivity was associated with age, gender, tumour location, tumour size > 2 cm, lymphovascular invasion, oestrogen and progesterone receptor status. Among 63 patients with a negative axillary PET status, 56 (88.9 %) had three or fewer involved nodes, whereas among 41 patients with a positive axillary PET status, 25 (61.0 %) had more than three positive nodes (P < 0.0001). In the survival analysis of preoperative characteristics, PET axillary node positivity was the foremost statistically significant factor associated with decreased disease-free survival (hazard ratio 2.81, 95% CI 1.17-6.74). Preoperative PET axillary node positivity identified patients with a higher burden of nodal involvement, which might be important for treatment decisions in breast cancer patients.
引用
收藏
页码:1618 / 1627
页数:10
相关论文
共 38 条
  • [1] Almubarak M, 2009, ONCOLOGY-NY, V23, P255
  • [2] [Anonymous], 2019, NCCN CLIN PRACTICE G
  • [3] Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up
    Avril, A.
    Le Bouedec, G.
    Lorimier, G.
    Classe, J. M.
    Tunon-de-Lara, C.
    Giard, S.
    MacGrogan, G.
    Debled, M.
    Mathoulin-Pelissier, S.
    Mauriac, L.
    [J]. EJSO, 2011, 37 (07): : 563 - 570
  • [4] F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging
    Avril, Norbert
    Adler, Lee P.
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2007, 45 (04) : 645 - +
  • [5] Bral S, 2008, STRAHLENTHER ONKOL, V184, P100, DOI 10.1007/s00066-008-1769-7
  • [6] A systematic review of FDG-PET in breast cancer
    Escalona, S.
    Blasco, J. A.
    Reza, M. M.
    Andradas, E.
    Gomez, N.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (01) : 114 - 129
  • [7] Facey K, 2007, HEALTH TECHNOL ASSES, V11, P1
  • [8] Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer
    Gil-Rendo, A.
    Martinez-Regueira, F.
    Zornoza, G.
    Garcia-Velloso, M. J.
    Beorlegui, C.
    Rodriguez-Spiteri, N.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (02) : 166 - 170
  • [9] Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
    Giuliano, Armando E.
    Hunt, Kelly K.
    Ballman, Karla V.
    Beitsch, Peter D.
    Whitworth, Pat W.
    Blumencranz, Peter W.
    Leitch, A. Marilyn
    Saha, Sukamal
    McCall, Linda M.
    Morrow, Monica
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (06): : 569 - 575
  • [10] Groheux D, 2007, B CANCER, V94, P658